Sigurdur Olafsson
Overview
Explore the profile of Sigurdur Olafsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Razavi H, Waked I, Qureshi H, Kondili L, Duberg A, Aleman S, et al.
J Hepatol
. 2025 Feb;
PMID: 39914746
Background And Aims: The year 2023 marked the 10-year anniversary of the launch of direct-acting antivirals (DAAs) for the treatment of the hepatitis C virus (HCV). HCV treatment trends by...
2.
Olafsson S, Love T, Fridriksdottir R, Tyrfingsson T, Runarsdottir V, Hansdottir I, et al.
Int J Drug Policy
. 2024 Oct;
133:104616.
PMID: 39454253
Background: Limited data exists about treatment outcomes in nationwide hepatitis C virus (HCV) elimination programs where injection drug use (IDU) is the main mode of transmission. In 2016 Iceland initiated...
3.
Haraldsson H, Olafsson S, Gottfredsson M, Hernandez U, Bjornsson E
Scand J Gastroenterol
. 2024 Apr;
59(7):835-842.
PMID: 38676467
Objective: In 2016, a nationwide elimination program for hepatitis C virus (HCV) was initiated in Iceland, entitled Treatment as Prevention for Hepatitis C (TraP HepC), providing unrestricted access to antiviral...
4.
5.
Sveinbjornsson G, Ulfarsson M, Thorolfsdottir R, Jonsson B, Einarsson E, Gunnlaugsson G, et al.
Nat Genet
. 2022 Oct;
54(11):1652-1663.
PMID: 36280732
Nonalcoholic fatty liver (NAFL) and its sequelae are growing health problems. We performed a genome-wide association study of NAFL, cirrhosis and hepatocellular carcinoma, and integrated the findings with expression and...
6.
Pham H, Reisner J, Swift A, Olafsson S, Vardeman S
Front Plant Sci
. 2022 Oct;
13:975976.
PMID: 36204056
Phenotypic variation in plants is attributed to genotype (G), environment (E), and genotype-by-environment interaction (GEI). Although the main effects of G and E are typically larger and easier to model,...
7.
Johannesson J, Fridriksdottir R, Love T, Runarsdottir V, Hansdottir I, Love A, et al.
Clin Infect Dis
. 2022 Apr;
75(10):1732-1739.
PMID: 35438144
Background: The Treatment as Prevention for Hepatitis C program started in 2016 in Iceland, offering treatment with direct-acting antivirals to hepatitis C virus (HCV)-infected individuals. Reinfections through injection drug use...
8.
Haering C, McMahon B, Harris A, Weis N, Lundberg Ederth J, Axelsson M, et al.
Int J Circumpolar Health
. 2021 Oct;
80(1):1986975.
PMID: 34668463
Hepatitis B virus (HBV) infection remains a global health threat. The World Health Organization (WHO) established a goal to eliminate HBV infection as a public health threat by 2030, and...
9.
Olafsson S, Fridriksdottir R, Love T, Tyrfingsson T, Runarsdottir V, Hansdottir I, et al.
Lancet Gastroenterol Hepatol
. 2021 Jun;
6(8):628-637.
PMID: 34171267
Background: WHO has set targets to eliminate hepatitis C virus (HCV) infection as a global health threat by 2030 through a 65% reduction in HCV-related deaths and 80% reduction in...
10.
Olafsson S, Rognvaldsson S, Bergmann O, Jonasson J, Hernandez U, Bjornsson E
JHEP Rep
. 2021 May;
3(3):100282.
PMID: 34041467
Background & Aims: The incidence of cirrhosis in Iceland has been the lowest in the world with only 3 cases per 100,000 inhabitants. Alcohol consumption has almost doubled in Iceland...